6533b835fe1ef96bd129fffd

RESEARCH PRODUCT

Cloning of Several Genes Coding for Retinoic Acid Nuclear Receptors in the Mouse Embryonal Carcinoma Cell Line PCC7–MZ1

Reinhard HeiermannAlfred MaelickeMartin RentropElke Lang

subject

Embryonal Carcinoma Stem CellsReceptors Retinoic AcidSomatic cellCellular differentiationMolecular Sequence DataRetinoic acidTretinoinBiologyEmbryonal carcinomaMicechemistry.chemical_compoundTumor Cells CulturedmedicineAnimalsHumansAmino Acid SequenceCloning MolecularPromoter Regions GeneticGenePharmacologyCloningBase SequenceNuclear ProteinsEmbryonal Carcinoma Stem CellsCell DifferentiationDNAmedicine.diseaseMolecular biologyRecombinant ProteinsRetinoic acid receptorchemistryNeoplastic Stem CellsCarrier Proteins

description

Mouse embryonal carcinoma cell line PCC7-Mz1 can be induced by retinoic acid (RA) to differentiate into several well defined phenotypes of neuroectodermal origin (Lang, E. et al. (1989) J. Cell. Biol. 109, 2481-2493). Several subclones of the cell line (clonal variants) differ from each other in their developmental potential. To test whether these differences in cellular fate are due to somatic mutations in specific genes of these cells, we have cloned full length cDNAs coding for the alpha 1 and beta 2 isoforms, and partial length cDNAs coding for the alpha 2, beta 1 and beta 3 isoforms of the retinoic acid nuclear receptor (RAR). The cloned cDNAs did not differ in sequence from those of normal mouse cells. Using as probe the beta 2-RAR promoter region from mouse liver, we also checked for restriction fragment length polymorphism in the promoter regions of RA-inducible and RA-resistant cell variants. No alterations in this region of RAR genes was found in the clonal variants tested. The different patterns of derivatives produced by the variants upon exposure to RA therefore cannot be caused by somatic mutations in RAR genes of the tumor cell lines.

https://doi.org/10.3109/10799899309073687